ATE121619T1 - Verfahren zum geschmacksabdecken von ibuprofen. - Google Patents

Verfahren zum geschmacksabdecken von ibuprofen.

Info

Publication number
ATE121619T1
ATE121619T1 AT91904188T AT91904188T ATE121619T1 AT E121619 T1 ATE121619 T1 AT E121619T1 AT 91904188 T AT91904188 T AT 91904188T AT 91904188 T AT91904188 T AT 91904188T AT E121619 T1 ATE121619 T1 AT E121619T1
Authority
AT
Austria
Prior art keywords
ibuprofen
taste covering
taste
covering
controlled release
Prior art date
Application number
AT91904188T
Other languages
English (en)
Inventor
Robert Wu-Wei Shen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE121619T1 publication Critical patent/ATE121619T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91904188T 1990-04-11 1991-02-26 Verfahren zum geschmacksabdecken von ibuprofen. ATE121619T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50819390A 1990-04-11 1990-04-11

Publications (1)

Publication Number Publication Date
ATE121619T1 true ATE121619T1 (de) 1995-05-15

Family

ID=24021750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904188T ATE121619T1 (de) 1990-04-11 1991-02-26 Verfahren zum geschmacksabdecken von ibuprofen.

Country Status (14)

Country Link
US (1) US5552152A (de)
EP (1) EP0524180B1 (de)
JP (1) JPH05506011A (de)
AT (1) ATE121619T1 (de)
AU (1) AU639988B2 (de)
CA (1) CA2076983A1 (de)
DE (1) DE69109282T2 (de)
DK (1) DK0524180T3 (de)
ES (1) ES2071986T3 (de)
FI (1) FI924589A0 (de)
HU (2) HUT64220A (de)
NO (1) NO300758B1 (de)
RU (1) RU2101010C1 (de)
WO (1) WO1991015194A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CA2395558C (en) * 1997-11-12 2007-07-17 Bayer Aktiengesellschaft Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6794411B1 (en) 1999-04-06 2004-09-21 Laboratoire Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
EP1181010A4 (de) * 1999-04-06 2003-03-26 Wrigley W M Jun Co Pharmazeutische kaugummiformulierungen
CA2380449A1 (en) 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
US8124124B2 (en) 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
DE60128215T2 (de) 2000-04-20 2008-01-10 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
RU2241451C1 (ru) * 2000-11-28 2004-12-10 Комиссарова Ирина Алексеевна Фармацевтическая композиция, ее применение и способ получения
RU2203042C2 (ru) * 2000-11-28 2003-04-27 Комиссарова Ирина Алексеевна Фармацевтическая композиция и способ ее получения
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
ES2323264T3 (es) * 2001-08-01 2009-07-10 Novartis Ag Composicion para enmascaramiento del sabor.
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
MXPA04008100A (es) 2002-02-21 2005-06-17 Biovail Lab Int Srl Formulaciones de liberacion modificada de al menos una forma de tramadol.
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
JP2007031281A (ja) * 2003-06-25 2007-02-08 Kowa Co イブプロフェン含有フィルムコーティング錠剤
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
US20070134493A1 (en) * 2005-12-08 2007-06-14 Kanji Meghpara Compositions and capsules with stable hydrophilic layers
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
EP2170051A1 (de) * 2007-07-01 2010-04-07 Joseph Peter Habboushe Kombinationstablette mit kaubarer aussenschicht
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
CA2853804C (en) 2011-10-28 2021-06-01 Vitalis Llc Anti-flush compositions
PT2833880T (pt) * 2012-04-02 2017-12-06 Pharma Seeds Create Llc Composição de dosagem oral sólida de ibuprofeno compreendendo um copolímero de ácido metacrílico
US8993041B2 (en) 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
RU2576236C1 (ru) * 2014-08-22 2016-02-27 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2577689C1 (ru) * 2014-08-26 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2578408C1 (ru) * 2014-09-10 2016-03-27 Александр Александрович Кролевец Способ получения нанокапсул алкалоидов
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
RU2688148C1 (ru) * 2016-05-10 2019-05-20 Александр Александрович Кролевец Способ получения нанокапсул экоцида в каррагинане
CN110917165A (zh) * 2019-12-26 2020-03-27 北京鑫开元医药科技有限公司海南分公司 一种布洛芬口崩片及其制备方法
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
FI924589A7 (fi) 1992-10-09
NO923947L (no) 1992-10-09
DE69109282D1 (de) 1995-06-01
NO300758B1 (no) 1997-07-21
HU9203193D0 (en) 1992-12-28
RU2101010C1 (ru) 1998-01-10
HUT64220A (en) 1993-12-28
JPH05506011A (ja) 1993-09-02
FI924589L (fi) 1992-10-09
AU639988B2 (en) 1993-08-12
NO923947D0 (no) 1992-10-09
US5552152A (en) 1996-09-03
EP0524180B1 (de) 1995-04-26
ES2071986T3 (es) 1995-07-01
HU211247A9 (en) 1995-11-28
AU7256091A (en) 1991-10-30
CA2076983A1 (en) 1991-10-12
DE69109282T2 (de) 1995-09-28
WO1991015194A1 (en) 1991-10-17
DK0524180T3 (da) 1995-09-04
EP0524180A1 (de) 1993-01-27
FI924589A0 (fi) 1992-10-09

Similar Documents

Publication Publication Date Title
ATE121619T1 (de) Verfahren zum geschmacksabdecken von ibuprofen.
DE69120665D1 (de) Selbsttätige vorrichtung zum verbinden von bahnen
DE59104603D1 (de) Vorrichtung zum Verlagern von Patienten.
DE3769687D1 (de) Kontinuierliches verfahren zum tablettieren.
DE69106001D1 (de) Vorrichtung zum automatischen einleiten von herzkammerflimmern.
DE3885884D1 (de) Gerät zum Anlegen von oesophageal-intestinalen Anastomosen.
DE68908326D1 (de) Verfahren zum herstellen elektrochromer vorrichtungen.
DE3878287D1 (de) Vorrichtung zum aufbringen eines bandes.
DE3870883D1 (de) Verfahren zum ueberziehen.
DE58900516D1 (de) Verfahren zum pelletieren.
DE69101933D1 (de) Vorrichtung zum Auftragen von Bildern.
FI894251A7 (fi) Menetelmä hiilihydraattipitoisten väliaineiden käyttämiseksi
DE3866017D1 (de) Vorrichtung zum hydraulischen aufweiten.
DE3874405D1 (de) Vorrichtung zum unterscheiden von bildbereichen.
DE3773856D1 (de) Verfahren zum eindampfen fotografischer ablaugen.
DE3870337D1 (de) Kulturapparat.
DE58901568D1 (de) Verfahren zum aufnehmen einzelner flaechiger gebilde.
DE3773869D1 (de) Verfahren zum eindampfen fotografischer ablaugen.
DE3884275D1 (de) Vorrichtung zum Entfernen von Haspeln.
DE58901845D1 (de) Verfahren zum festlegen.
DE69007286D1 (de) Verfahren zum fotografischen verfahren.
DE69101381D1 (de) Einrichtung zum anlegen von prothesen.
DE69107480D1 (de) Vorrichtung zum anbringen von streifen.
DE68905163D1 (de) Verfahren zum sterilisieren.
DE58908513D1 (de) Verfahren zum Spulenwechsel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee